RecruitingPhase 3NCT06774131
Oncology
Upper tract urothelial carcinoma
49
studies recruiting now
as of 7 Sept 2026
123
studies registered in total
as of 7 Sept 2026
9
countries with a recruiting site
as of 7 Sept 2026
5 Dec 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2 / Phase 3NCT04628767
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
RecruitingPhase 1 / Phase 2NCT06668493
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
RecruitingPhase 2NCT07265947
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
RecruitingNot applicableNCT06040762
A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 49 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Upper tract urothelial carcinoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Upper tract urothelial carcinoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
2 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 2Avelumab (Bavencio)
Phase 1/2Infigratinib
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).